These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 3917885

  • 1. Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex.
    Steadham JE, Stall SK, Simmank JL.
    Diagn Microbiol Infect Dis; 1985 Jan; 3(1):33-40. PubMed ID: 3917885
    [Abstract] [Full Text] [Related]

  • 2. Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods.
    Trimble KA, Clark RB, Sanders WE, Frankel JW, Cacciatore R, Valdez H.
    J Antimicrob Chemother; 1987 May; 19(5):617-22. PubMed ID: 3112096
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.
    Wallace RJ, Nash DR, Steele LC, Steingrube V.
    J Clin Microbiol; 1986 Dec; 24(6):976-81. PubMed ID: 3097069
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
    Molina-Torres CA, Ocampo-Candiani J, Rendón A, Pucci MJ, Vera-Cabrera L.
    Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
    [Abstract] [Full Text] [Related]

  • 5. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y, Cabral C, Shapiro DS, McGrath P.
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
    Texier-Maugein J, Mormède M, Fourche J, Bébéar C.
    Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050
    [Abstract] [Full Text] [Related]

  • 7. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
    Litvinov V, Makarova M, Galkina K, Khachaturiants E, Krasnova M, Guntupova L, Safonova S.
    PLoS One; 2018 Oct; 13(9):e0203108. PubMed ID: 30222736
    [Abstract] [Full Text] [Related]

  • 8. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
    Thomas L, Naumann P, Crea A.
    Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
    [Abstract] [Full Text] [Related]

  • 9. Two groups of Mycobacterium avium complex strains determined according to the susceptibility to rifampicin and ansamycin.
    Tsukamura M.
    Microbiol Immunol; 1987 Nov; 31(7):615-23. PubMed ID: 3125413
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative in vitro activity of the new macrolide A-56268 against mycobacteria.
    Berlin OG, Young LS, Floyd-Reising SA, Bruckner DA.
    Eur J Clin Microbiol; 1987 Aug; 6(4):486-7. PubMed ID: 2959472
    [No Abstract] [Full Text] [Related]

  • 15. Use of Gen-Probe AccuProbes to identify Mycobacterium avium complex, Mycobacterium tuberculosis complex, Mycobacterium kansasii, and Mycobacterium gordonae directly from BACTEC TB broth cultures.
    Reisner BS, Gatson AM, Woods GL.
    J Clin Microbiol; 1994 Dec; 32(12):2995-8. PubMed ID: 7883888
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
    Davies S, Sparham PD, Spencer RC.
    J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
    [Abstract] [Full Text] [Related]

  • 18. [Utility of the direct culture examination (Ziehl-Neelsen) using the Bactec system for the presumptive identification of Mycobacterium tuberculosis complex, Mycobacterium avium complex, Mycobacterium xenopi, and Mycobacterium kansasii].
    Moreno C, Garrigó M, Sánchez F, Coll P.
    Enferm Infecc Microbiol Clin; 1994 May; 12(5):241-5. PubMed ID: 7811323
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the mycobacteria growth indicator tube with radiometric and solid culture for isolation of mycobacteria from clinical specimens and susceptibility testing of Mycobacterium tuberculosis.
    Ardito F, Sanguinetti M, Sechi L, Posteraro B, Masucci L, Fadda G, Zanetti S.
    New Microbiol; 2000 Apr; 23(2):151-8. PubMed ID: 10872685
    [Abstract] [Full Text] [Related]

  • 20. Bacteriostatic and bactericidal activity of antituberculosis drugs against Mycobacterium tuberculosis, Mycobacterium avium-Mycobacterium intracellulare complex and Mycobacterium kansasii in different growth phases.
    Yamori S, Ichiyama S, Shimokata K, Tsukamura M.
    Microbiol Immunol; 1992 Apr; 36(4):361-8. PubMed ID: 1406364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.